Skip to main content
Contact Us
Subscribe
E-Edition
89°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Abeona Therapeutics Inc.
< Previous
1
2
Next >
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
Today 7:30 EDT
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy
July 01, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 01, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index
June 30, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
June 24, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
May 30, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates
May 15, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
May 14, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
May 14, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million
May 12, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 07, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
April 29, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
March 20, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
March 04, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 03, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 31, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
November 14, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
November 12, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces Participation in November Investor Conferences
November 04, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
October 29, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
September 03, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
August 14, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
August 13, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.